Ryan removes indicted GOP lawmaker from House Energy and Commerce Committee

Ryan removes indicted GOP lawmaker from House Energy and Commerce Committee

House Speaker Paul RyanPaul Davis RyanFormer Dem candidate says he faced cultural barriers on the campaign trail because he is working-class Former House candidate and ex-ironworker says there is 'buyer's remorse' for Trump in Midwest Head of top hedge fund association to step down MORE (R-Wis.) on Wednesday said Rep. Chris CollinsChristopher (Chris) Carl CollinsThe 23 Republicans who voted against the anti-hate resolution House passes anti-hate measure amid Dem tensions Don’t look for House GOP to defy Trump on border wall MORE (R-N.Y.) has been removed from his post on the House Energy and Commerce Committee as a result of the lawmaker's indictment on insider trading charges.

Collins was arrested and charged with federal securities fraud related to an Australian pharmaceutical company of which he had been the largest shareholder.

ADVERTISEMENT

“While his guilt or innocence is a question for the courts to settle, the allegations against Rep. Collins demand a prompt and thorough investigation by the House Ethics Committee," Ryan said in a statement. "Insider trading is a clear violation of the public trust. Until this matter is settled, Rep. Collins will no longer be serving on the House Energy and Commerce Committee.”

House Majority Whip Steve ScaliseStephen (Steve) Joseph ScaliseConservatives wage assault on Mueller report Meadows says Mueller's end proves 'no collusion' House Dem renews call for censuring Steve King MORE (R-La.) backs the Speaker’s decision to remove Collins from the committee, a Scalise spokesman told The Hill.

According to the indictment, Collins's son, Cameron Collins, and Stephen Zarsky, the father of Cameron Collins's fiancée, are also being charged.

The Buffalo-area congressman turned himself in to the FBI and is slated to appear in court later in the day, NBC News reported.

An Office of Congressional Ethics report released in 2017 stated there is “substantial reason to believe” he shared nonpublic information about the Australian pharmaceutical company.